IntegraGen is a molecular research firm that develops and commercializes molecular diagnostic tests for autism and oncology.
Business Model:
Revenue: $12.8M
Employees: 11-50
Address: 5, Rue de Henri Desbrueres
City: Evry
State: île-de-france
Zip: 91000
Country: FR
IntegraGen is a molecular research firm that develops and commercializes molecular diagnostic tests for autism and oncology.
Contact Phone:
Contact Email:
Listed Exchange:
PA
IPO Date:
6/25/2010
Ticker Symbol:
ALINT
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2012 | Post-IPO Equity | $2.4M | 6/2010 | Venture Round | 5 | - |
Generis Capital Partners Bank of the Philippine Islands Amundi Private Equity Funds BayTech Venture Capital Innovation Capital Generis Capital Partners Bank of the Philippine Islands Amundi Private Equity Funds BayTech Venture Capital Innovation Capital |
11/2005 | Series B | 5 | $9.4M |
BayTech Venture Capital Idinvest Partners CDC Enterprises Bioam Gestion Societe Generale Asset Management BayTech Venture Capital Idinvest Partners CDC Enterprises Bioam Gestion |
11/2006 | Venture Round | 1 | $2.5M |
DSM Venturing DSM Venturing DSM Venturing DSM Venturing |
6/2010 | Venture Round | 5 | - |
Generis Capital Partners Bank of the Philippine Islands Amundi Private Equity Funds BayTech Venture Capital Innovation Capital Generis Capital Partners Bank of the Philippine Islands Amundi Private Equity Funds BayTech Venture Capital Innovation Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|